Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

IL-6 from stem cells helps repair skin and grow hair.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The model and estimator can predict drug exposure in kidney transplant patients well.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Non-coding RNAs could help detect and treat radiation damage.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.